Medicine and Dentistry
T Cell
73%
Chimeric Antigen Receptor
57%
Chimeric Antigen Receptor T-Cell
48%
Solid Malignant Neoplasm
34%
Immunotherapy
32%
Neoplasm
30%
Cancer
27%
Malignant Neoplasm
24%
Receptor
23%
Chimeric Antigen Receptor T-Cell Immunotherapy
22%
Cell Therapy
14%
ErbB
14%
Clinical Trial
14%
Integrin
14%
Diseases
13%
Alendronic Acid
12%
Positron Emission Tomography
12%
B Cell
11%
Mesothelioma
10%
Krukenberg Tumor
10%
Cancer Immunotherapy
9%
Regulatory T Cell
9%
T Lymphocyte Receptor
9%
Adoptive Immunotherapy
8%
Antineoplastic Activity
8%
Xenograft
8%
CD3 Antigen
8%
Breast Cancer
7%
Hematologic Malignancy
7%
Antigen Specificity
7%
Tumor Cell
7%
Mucin 1
7%
Chimeric Antigen Receptor T-Cell Therapy
7%
Immunosuppressive Drug
6%
Iodine 124
6%
Infection
6%
Single-Photon Emission Computed Tomography
6%
Systematic Review
6%
Prostate Specific Membrane Antigen
6%
Cholangiocarcinoma
6%
Cell Surface
5%
Liposome
5%
Ex Vivo
5%
Tumor Antigen
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Antigen Receptor
100%
Immunotherapy
91%
Solid Malignant Neoplasm
57%
Neoplasm
55%
Malignant Neoplasm
39%
Receptor
22%
Clinical Trial
18%
Alendronic Acid
16%
Diseases
13%
Integrin
12%
Cytokine
11%
Antitumor Activity
11%
Ovary Carcinoma
10%
Mucin 1
10%
Colony Stimulating Factor 1
9%
Hematologic Malignancy
9%
Tumor Microenvironment
8%
Interleukin 4
7%
Head and Neck Squamous Cell Carcinoma
7%
Immunosuppressive Agent
6%
Interleukin 6
6%
Interleukin 2
6%
Acute Myeloid Leukemia
6%
Liposome
5%
Prostate Cancer
5%
Dimer
5%
Breast Cancer
5%
CD3 Antigen
5%
Tumor Antigen
5%
Combination Therapy
5%
Biodistribution
5%
Chemotherapy
5%
Immunology and Microbiology
T Cell
88%
Chimeric Antigen Receptor
59%
Chimeric Antigen Receptor T-Cell
50%
Immunotherapy
39%
Cancer Immunotherapy
17%
Regulatory T Cell
17%
Integrin
15%
Adoptive Immunotherapy
15%
Cytokine
14%
Tumor Cell
13%
T Cell Receptor
13%
Macrophage Colony-Stimulating Factor
12%
Antineoplastic Activity
12%
CD28
12%
Gene Transfer
11%
MUC1
10%
Tumor Antigen
10%
Cell Surface
9%
B Cell
9%
Chimeric Antigen Receptor T-Cell Therapy
8%
Interleukin 2
8%
CD19
7%
Interleukin 4
7%
Cancer Cell
7%
Natural Killer Cell
7%
CD3 Antigen
7%
Immunology
6%
Cell Differentiation
6%
Prostate Specific Membrane Antigen
6%
Single Photon Emission Computed Tomography
6%
Cytotoxic T Cell
6%
Monoclonal Antibody
6%
Cell Activation
6%
Myeloid
5%
Antigen Specificity
5%
Cytokine Receptor
5%
Effector Cell
5%
Immune System
5%